MedPath

Relationship Between EIT and Respiratory Status in Very Preterm Infants

Not Applicable
Completed
Conditions
Chronic Lung Disease of Prematurity
Bronchopulmonary Dysplasia
Premature Lungs
Interventions
Device: Sentec LuMon Device (EIT system)
Device: Sentec Digital Monitoring System (transcutaneous CO2 monitor)
Registration Number
NCT06609135
Lead Sponsor
Lawrence Rhein
Brief Summary

Electrical Impedance Tomography (EIT) is a non-invasive imaging technique that can measure lung function in real time. This study will follow premature infants to see if EIT can help predict which infants will be successful in weaning off respiratory support by 32-33 weeks gestational age. If successful, EIT could be used to develop new guidelines for respiratory support in premature infants.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Infants admitted to the UMass Memorial Medical Center (UMMMC) Neonatal Intensive Care Unit (NICU)
  • Born between 25+0- and 29+6-weeks of gestation
Exclusion Criteria
  • Infants with major congenital anomalies
  • Infants with severe hemodynamic instability

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Electrical Impedance Tomography (EIT) and CO2 monitorSentec LuMon Device (EIT system)Participating infants will have the EIT belt placed at a minimum of twice per week throughout the NICU stay. A respiratory therapist or physician will place the EIT belt at the end of a feed and remove it at the next feed. A transcutaneous CO2 monitor will be placed concurrently.
Electrical Impedance Tomography (EIT) and CO2 monitorSentec Digital Monitoring System (transcutaneous CO2 monitor)Participating infants will have the EIT belt placed at a minimum of twice per week throughout the NICU stay. A respiratory therapist or physician will place the EIT belt at the end of a feed and remove it at the next feed. A transcutaneous CO2 monitor will be placed concurrently.
Primary Outcome Measures
NameTimeMethod
Discontinuation of respiratory support at 32 weeks corrected gestational ageAt 32 weeks corrected gestational age

Successful discontinuation of non-invasive ventilation at 32 weeks corrected gestational age.

Discontinuation of respiratory support at 33 weeks corrected gestational ageAt 33 weeks corrected gestational age

Successful discontinuation of non-invasive ventilation at 33 weeks corrected gestational age.

Change in EIT measurements with titration of noninvasive respiratory supportUntil positive end expiratory pressure support is discontinued, approximately 3 weeks

EIT values at set positive end expiration pressure levels.

Correlation between EIT measurements and TCOM measurementsThrough study completion, an average of 8 weeks

Mean transcutaneous CO2 levels

Correlation between EIT measurements and time to full oral feedingThrough study completion, an average of 8 weeks

Duration of time required for successful full oral feeding.

Correlation between EIT measurements and BPD status at 36 weeksAt 36 weeks corrected gestational age

Bronchopulmonary dysplasia (BPD) status at 36 weeks corrected gestation.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

UMASS Memorial Medical Center

🇺🇸

Worcester, Massachusetts, United States

© Copyright 2025. All Rights Reserved by MedPath